Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Antiviral Chemistry & Chemotherapy|June 5, 2007
The threat of avian influenza H5N1: 'do we have the tools for the job'?John Oxford, Robert Lambkin-Williams, Alex MannSAGE Open Medicine|October 8, 2020
Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell lineRob Lambkin-Williams, Alex Mann, Adrian ShephardACS Applied Materials & Interfaces|February 9, 2011
Mechanism of recombination losses in bulk heterojunction P3HT:PCBM solar cells studied using intensity modulated photocurrent spectroscopyJoshua C Byers, Scott Ballantyne, Konstantin Rodionov, et al.Respiratory Research|June 23, 2018
The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnosticsRob Lambkin-Williams, Nicolas Noulin, Alex Mann, et al.BMC Research Notes|August 31, 2018
The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development processAndrew P Catchpole, Daniel J Fullen, Nicolas Noulin, et al.Wellcome Open Research|May 4, 2022
Human infection studies: Key considerations for challenge agent development and productionShobana Balasingam, Sarah Meillon, Cecilia Chui, et al.Vaccine|October 12, 2004
Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccineRob Lambkin, John S Oxford, Seb Bossuyt, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 15, 2026
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus InfectionStuart Byrne, Takamichi Baba, Nao Kawaguchi, et al.Plos One|December 23, 2016
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with InfectionRob Lambkin-Williams, Colin Gelder, Richard Broughton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2018
The Effect of Influenza Virus on the Human Oropharyngeal MicrobiomeElisa Ramos-Sevillano, William G Wade, Alex Mann, et al.Pageof 3